Influence Of Active Cancer On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II.

Pas encore traduit Pas encore traduit
Catégorie Primary study
Year 2013

Cet article est inclus dans 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
  • RE-COVER I [Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism] (15 documents)
  • RE-COVER II [Phase III Study Testing Efficacy and Safety of Oral Dabigatran Etexilate versus Warfarin for 6 Month Treatment for Acute Symptomatic Venous Thromboembolism (VTE)] (12 documents)
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: a5082caa3dd3de89901f46d0d16e3912da5ad05a
First added on: Apr 23, 2018